7 Pharma Stocks to Avoid at All Costs in 2018 - 1 of 8


 
7 Pharma Stocks to Avoid at All CostsThe pharmaceutical sector has been on a roller coaster ride over the last several years. As recently as 2016, the industry was getting pinched by the double whammy of pressure to reduce drug costs and a corporate tax structure that was choking off topline growth. In the last year, many of the pharmaceutical companies have seen their stocks go through the roof as a result of the new tax policy. But not every pharmaceutical stock is showing strength.

Make no mistake, this is an industry that every investor – and every consumer – should want to see succeed. These companies are continuously introducing new drugs and treatments for cancer, Alzheimer’s, diabetes, and multiple sclerosis just to name a few. And that’s not to mention the drugs that help us manage our cholesterol, high blood pressure, and depression.

Not to mention, the baby boomer generation continues to reach retirement age. In 2018 alone, over three million people will be reaching retirement age and that pace isn’t expected to slow down significantly until 2029. As the number of retirees expands so too will their need for the products and services that come from this industry.

It’s expensive to develop these drugs, not to mention that it can take years for some of these products to reach the market. Our desire to want to believe in these treatments can allow investors to mistake an inflated valuation for a poor valuation.

But as an investor, we have to perform our due diligence, and there are some stocks that have qualitative or quantitative factors working against them. While the pharmaceutical is always changing, we’re providing a list of seven stocks that, for now, should stay out of your portfolio.

Click the "Continue to Slide #2" button view the first company.





More on MarketBeat
15 Stocks that Insiders Love15 Stocks that Insiders Love
15 REITS Analysts Can15 REITS Analysts Can't Stop Recommending
12 Marijuana Stocks to Buy Now12 Marijuana Stocks to Buy Now
8 Stocks That Are on Sale Right Now8 Stocks That Are on Sale Right Now
7 Stocks Set for Monster Growth in 20197 Stocks Set for Monster Growth in 2019
9 Marijuana Stocks to Play the Pot Craze9 Marijuana Stocks to Play the Pot Craze
Analysts Hate These 12 StocksAnalysts Hate These 12 Stocks





Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel